Previous 10 | Next 10 |
Gainers: Conduent (NASDAQ: CNDT ) +75% . More news on: Conduent Incorporated, OpGen, Inc., Groupon, Inc., Stocks on the move, , Read more ...
LAS VEGAS , Aug. 6, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has entered into an agreement with CATO SMS, a world-leading, internat...
LAS VEGAS , Aug. 4, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, announces a internal name change for its current drug candidate f...
LAS VEGAS , July 30, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties has added two members to its impressive scientific...
JanOne ( JAN +8.6% ) has received confirmation from the FDA for the IND sponsorship transfer covering its sodium nitrite tablets previously held by Soin Neuroscience, to the company. More news on: JanOne Inc., Healthcare stocks news, Stocks on the move, Read more ...
LAS VEGAS , July 21, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain-relieving properties, has received confirmation from the Federal Food and Drug Administratio...
LAS VEGAS , July 8, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties, continues to broaden the medical and clinical competenc...
LAS VEGAS , June 30, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties announced today that Edgar Ross , MD will join the com...
LAS VEGAS , June 25, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, continues to build a world-class team of biopharma experts with the additio...
LAS VEGAS , June 18, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq:JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, today announced the commencement of a strategic alternative process for...
News, Short Squeeze, Breakout and More Instantly...
JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA CORPORATION AND NEW TICKER SYMBOL TO ALTS Canada NewsWire LAS VEGAS , July 12, 2024 /CNW/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on fintech and healthcare, confirmed today that, as of ...
JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment Canada NewsWire -The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward- -The company is intending a name and stock symbol change...